Details of the Drug Formulaction

General Information of Drug Formulation (ID: F16014)

• Formulation Name: Ondansetron 8 mg tablet
• Company: A-S Medication Solutions; Aidarex Pharmaceuticals; Ascend Laboratories; DirectRX; Lake Eire Medical & Surgical Supply DBA Quality Care Products; Life Line Home Care Services; Proficient Rx; Ranbaxy Pharmaceuticals; RemedyRepack

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ondansetron	(DMOTQ1I)	Chemotherapy-induced nausea	MD90	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent